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A brain ischemia is a type of stroke that occurs when insufficient blood 
flow to the brain. This leads to reperfusion injury as well as. Reperfusion 
injury is when there blood supply returns to the brain circulation results in 
inflammation and oxidation damage on brain cell. Many drugs are based on 
improvements in existing therapies or on an understanding of the molecular 
mechanisms involved in oxidative stress. Cerebral ischemia is the third 
leading cause of death in industrial countries. Therefore, it is important to 
develop new compounds that are effective for the treatment of cerebral 
ischemia.  
 ii
This study evaluated the neuroprotective effects of Maclura tricuspidata 
fruits on the two experimental models of cerebral ischemic damage in in 
vitro model oxygen-glucose deprivation/reoxygenation (OGD/R) and in vivo 
model middle cerebral artery occlusion/reperfusion (MCAO/R) of cerebral 
ischemia. Also, the isolated compounds from M.tricuspidata friuits were 
investigated the protective effects in in vitro model of cerebral ischemia. 
50% EtOH extract of M. tricuspidata fruits (FME50) inhibited OGD/R-
induced neuronal cell death, ROS generation, and NADPH oxidase 4 (Nox4) 
expression via induction of Nox4-targeting miRNA-25, miRNA-92a, and 
miRNA-146a in SH-SY5Y cells. Also, FME50 suppressed OGD/R-induced 
activation of apoptosis signal-regulating kinase 1 (ASK1)- c-Jun N-terminal 
kinases1 (JNK1) / p38 mitogen-activated protein kinases (MAPK) signal 
cascade. Among nine isolates from FME50, cudraisoflavone I (CFI) and 
cudraisoflavone H (CFH) attenuated OGD/R-induced cell death, ROS 
generation, and Nox4 expression by regulating miRNA-25, miRNA-92a, and 
miRNA-146a expression. Furthermore, CFI and CFH inhibited MAPK 
signal cascade. Furthermore, FME50 significantly reduced the MCAO/R–
induced brain infarct, Nox4 expression via induction of Nox4-targeting three 
miRNAs. Additionally, FME50 suppressed MCAO/R-induced MAPK signal 
pathway.  
 iii
Taken together, these findings suggest that the neuroprotective effect of 
FME50 and two isolated compound CFI and CFH on neurotoxicity is in part 
due to the inhibition of NOX activity and ROS generation. These results 
demonstrate that FME50, CFI, and CFH exert neuroprotective effects via 
Nox4 inhibition by the induction of Nox4-targeting miRNAs and inhibition 
of MAPK signal cascade, suggesting that they might be possible candidates 
for the treatment of cerebral ischemia. 
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Figure 3. Structures of the principal compounds and UHPLC 
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Figure 5. The effects of FME50 on OGD/R-induced intracellular ROS 
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Figure 6. The inhibitory effects of FME50, CFI, CFH or VAS2870 on the 
expression of Nox4 mRNA                            35 
 
Figure 7. Quantitative comparison of the miRNA-25, miRNA-92a, and 
miRNA-146a level in the OGD/R-induced condition in SH-
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Figure 8. The inhibitory effects of FME50, CFI, CFH or VAS2870 on the 
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Figure 9. The inhibitory effects of FME50 or VAS2870 on Nox enzyme 
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Figure 10. Quantitative comparison of Nox4 mRNA level in OGD/R-
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Figure 11. Inhibitory effects of FME50, CFI, CFH or VAS2870 on the 
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Figure 12. The effect of carnosine on OGD/R-induced cell death in SH-
SY5Y cells was measured by an MTT reduction assay      49 
 
Figure 13. The effects of carnosine on OGD/R-induced intracellular ROS 
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Figure 14. The effects of FME50 on the MCAO/R-induced cerebral 
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Figure 15. Quantitative comparison of miRNA-25, miRNA-92a, and 
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Figure 16. The inhibitory effects of FME50 or carnosine on the expression 
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Figure 17. The effect of FME50 on protein expression in MCAO/R-
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Figure 18. Quantitative comparison of Ago1 mRNA level in OGD/R-
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Figure 19. Quantitative comparison of Ago2 mRNA level in OGD/R-






FME50              50% EtOH extract of Maclura tricuspidata fruits 
CFI                    Cudraisoflavone I  
CFH                   Cudraisoflavone H  
Nox                    NADPH oxidase  
OGD/R              Oxygen-glucose deprivation/reoxygenation 
MCAO/R           Middle cerebral artery occlusion/reperfusion  
MAPK                Mitogen-activated protein kinases  
ASK1                  Apoptosis signal-regulating kinase 1  
JNK1                   c-Jun N-terminal kinases1  
P38                      Mitogen-activated protein kinase 
ROS                     Reactive oxygen species    
UPLC                  Ultra performance liquid chromatography 




Maclura tricuspidata Carrière (formerly known as Cudrania tricuspidata, 
Moraceae) is a tree widespread in Korea, China, and Japan and the ripe fruits 
can be eaten by hand or commercially used as pies, sherbets, tarts and wines. 
M. tricuspidata contains prenylated isoflavonoids, benzylated flavonoids, 
xanthones, quercetin and kaempferol (Hiep et al., 2015a; Han et al., 2009; Lee 
et al., 1995; Lee et al., 1996; Kim et al., 2009) and it showed anti-
atherosclerotic and anti-inflammatory (Park et al., 2006), hepatoprotective 
(Tian et al., 2005), neuroprotective (Jeong et al., 2010), pancreatic lipase 
inhibitory (Jeong et al., 2014), antihypertensive (Kang et al., 2002), and 
antiallergic activities (Lee et al., 2015). Cudraisoflavone I (CFI) and 
cudraisoflavone H (CFH) from the fruit of M. tricuspidata were previously 
reported to have neuroprotective effects against 6-hydroxydopamine-induced 
cell death in SH-SY5Y cell (Hiep et al., 2015a). 
Cerebral reperfusion injury initially caused by ischemia is due to insufficient 
blood supply to the brain, and this leads to poor oxygen supply and eventually 
neuronal cell death. After the ischemic period, reperfusion or reoxygenation 
is essential for survival of neuronal cells. However, the restoration of blood 
circulation results in the overproduction of mitochondrial reactive oxygen 
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species (ROS) in neuronal cells, and thereby implicates the cellular damage 
during neurological diseases, such as stroke (Chouchani et al., 2014). 
Oxidative stress plays a major role in the pathogenesis of neurological 
disorders, such as cerebral ischemia. Many studies have shown that oxidative 
stress plays a pathological role in cerebral ischemia (Chan, 2001). These post-
ischemia oxidation reactions result in the overproduction of ROS in neuronal 
cells (Perjes et al., 2012). And the overproduction of intracellular ROS is an 
important factor to the pathogenesis of neurodegenerative disease of ischemia 
(Mei Jin et al., 2014. The majority of studies on the generation of ROS in brain 
ischemia have focused on the effects of mitochondrial dysfunction (Niizuma 
et al., 2010). Recently, attention has focused on the role of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase (NOX) (Youn et al., 2013). 
 NOX4, a NOX family of ROS-generating NADPH oxidases, is widely 
expressed in neurons, astrocytes, and microglia. When NOX4 expression is 
stimulated by external stress or brain injury, the cytosolic subunits migrate to 
the plasma membrane and form a functional complex with p22phox to 
generate ROS (Bedard and Krause, 2007). Recent studies suggest that ROS 
generated via the NOX family plays a major role in neurodegenerative 
diseases, such as cerebral ischemia (Sorce and Krause, 2009). It was reported 
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that the mitochondrial ROS can be formed by xanthine oxidase, cytochrome 
P450, nitric oxide synthase, and nicotinamide adenine dinucleotide phosphate 
oxidase (Nox). Human genome encodes seven members of the Nox family 
(Nox1 - Nox5, Duox1 and Duox2), and Nox is a membrane-bound enzyme 
complex composed of six subunits with different patterns of expression (K., 
2011). When Nox4 expression is stimulated by external stress or brain injury, 
the integral membrane protein p22phox forms a heterodimeric functional 
complex with Nox4 to generate ROS (Bedard and Krause, 2007), suggesting 
that ROS generated by the Nox4 activation plays a major role in cerebral 
ischemia. Recent studies reported that Nox activity is connected with Nox 
targeting miRNAs expression (Liu et al., 2016).  
MiRNAs are small noncoding RNAs with 19-25 nucleotides and regulates 
the basis cellular functions such as proliferation, differentiation, and death 
(Hwang and Mendell, 2006). MiRNAs are known to play an important role in 
many pathological processes in the brain (Adlakha and Saini, 2014) and some 
miRNAs are expressed in neuronal cell. Among them, three different miRNAs 
(miRNA-25, miRNA-92a, and miRNA-146a) are highly related in the 
regulation of Nox4 mRNA expression (Fu et al., 2010; Wang et al., 2014; Tsao 
et al., 2015). These miRNAs modulate protein expression by binding 
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complementary target mRNA and the target mRNA degradation or 
translational inhibition are occur (Jeyaseelan et al., 2008). It was reported that 
silencing of Nox4 mRNA expression inhibited ROS production (Wang et al., 
2014) and inhibited hypoxia-induced activation of apoptotic signals such as 
ASK1, JNK, and p38 (Mkaddem et al., 2010). Ischemia-induced ROS 
attributes in part to the activation of mitogen-activated protein kinases 
(MAPK).  
Apoptosis signal-regulating kinase 1 (ASK1) is an upstream regulator of 
MAPK cascade and activated by various stresses including oxidative stress, 
ER stress, calcium influx, receptor-mediated inflammatory signals and 
ischemic injuries (Ichijo et al., 2007). ASK1 activates c-Jun N-terminal 
kinases 1 (JNK1), known as a mediator of neuronal degeneration in response 
to stress, and phosphorylated p38 mitogen-activated protein kinase, one of 
apoptosis factors related MAPK (Irving and Bamford, 2002). The JNK1 was 
known to bind and phosphorylate the DNA binding protein c-Jun and elevate 
its transcriptional activity and the p38 kinase was expressed in most cell types 
and regulated of many cytokines. Inhibition of these proteins are cell survival 




Previously, we reported that isoflavones and extracts from fruits of M. 
tricuspidata exerted the neuroprotective effects against 6-OHDA-induced in 
cell death (Hiep et al., 2015a; Kim et al., 2017). In this stiudy, we investigated 
the neuroprotective effect of different extracts (0 – 100% ethanol ratio) and 
nine isoflavones from M. tricuspidata fruits in in vitro and in vivo models of 
cerebral ischemia. Our studies focused on the inhibition of intracellular ROS 
generation, Nox4 expression, induction of miRNAs (miRNA-25, miRNA-92a, 
and miRNA-146a) targeting Nox4 mRNA expression, and inhibition of 
apoptosis via ASK1-JNK/p38 MAPK signal cascade using oxygen-glucose 
deprivation/reoxygenation (OGD/R) in vitro model, and middle cerebral 




 2. Materials and Methods 
 
2.1. Chemicals and reagents 
2',7'-dichlorfluorescein-diacetate (DCFH-DA), carnosine, and VAS2870 (a 
NOX inhibitor), were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS) 
were purchased from HycloneTM Thermo scientific (Wyman Street Waltham, 
MA, USA). Hybond-polyvinylidene difluoride (PVDF) membrane purchased 
from Amersham Pharmacia Biotechnology Inc. (Piscataway, NJ, USA). Easy-
Blue® total RNA extraction solution, One Step RT-PCR Premix Kits, PRO-
PREP protein extraction solution and WEST-ZOL® ECL solution were 
purchased from iNtRON Biotechnology (Kyunggi, Korea). Nox4, ASK1, p-
ASK1, JNK1, p38, p-p38, β-actin primary antibody and secondary antibody 
purchased from Santa Cruz Biotechnology, Inc. (CA, U.S.A.). The miRNAs 
mimic and inhibitor (miRNA-25, miRNA-92a, miRNA-146a) were purchased 
from Applied Biosystems (Foster City, CA, USA). 
 
2.2. UPLC chromatogram of 50% EtOH extract from Maclura 
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tricuspidata fruits (FME50)  
All samples were analyzed using an Acquity UPLC system (Waters, Millford, 
MA, USA) equipped with an Acquity BEH C18 column (2.1 mm × 150 mm 
i.d., 1.7 μm). The mobile phases were consisted of 0.05% formic acid in water 
(A) and acetonitrile (B), with a flow rate of 0.3 mL/min. The initial eluent was 
35% B, and its proportion was increased linearly to 95% B until 10 min, held 
constant at 100% until 11.5 min, returned to the initial composition at 10.5 
min, and then held constant for 1.5 min to re-equilibrate the column. The 
sample injection volume was 4 μL for extracts and 2 μL for compounds. The 
column and sample managers were set at 35 and 15 °C, respectively, and the 
UV wavelength was monitored at 265 nm. 
 
2.3. Plant material and sample preparation 
The fruits of Maclura tricuspidata were collected from the Korea Forest 
Research Institute, Southern Forest Research Center (Jinju, Korea). A voucher 
specimen (accession no. KH1-5-090904) was deposited at the Department of 
Biosystems and Biotechnology, Korea University (Seoul, Korea). The dried 
fruits of M. tricuspidata (3.4kg, yield 18.88%, w/w) were ground and sifted 
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through a 120-mesh sieve. The partial of samples (7.0 g) were refluxed three 
times by means of heating mantle with 250 mL of each 0, 30, 50 70, and 100% 
ethanol for 1h. Each extract was combined, filtered, and concentrated in vacuo 
to obtain various samples (2.85 g, 2.71 g, 2.58 g, 2.67 g, and 2.15 g, 
respectively). The chemical investigation led to the isolation of nine 
isoflavones, namely, cudraisoflavone I (1, 0.0007%), cudraisoflavone H (2, 
0.0013%), gancaonin A (3, 0.0086%), 6,8-diprenylorobol (4, 0.0015%), 
alpinumisoflavone (5, 0.0762%), 4′-O-methylalpinumisoflavone (6, 
0.0046%), 6,8-diprenylgenistein (7, 0.0055%), isoerysenegalensein E (8, 
0.0221%), and erysenegalensein E (9, 0.0181%). Their structures were 
identified by interpretation of spectroscopic data, and the purity of each 
compound was more than 95%. Fresh fruits of Maclura tricuspidata (10.7 kg) 
were dried, ground, and extracted with EtOH (3 × 10.0 L) at room temperature, 
in 10 days. The extracts were evaporated in vacuo to afford a EtOH extract 
(TH1-1-1, 630.9 g), which was then suspended in H2O (2 × 2.5 L). The 
aqueous solution was partitioned with n-hexane (4 × 2.0 L) and EtOAc (5 × 
2.0 L) to give n-hexane (TH1-2-1, 48.4 g) and EtOAc (TH1-2-2, 27.8 g) 
soluble extracts. The EtOAc soluble extract was firstly fractionated by silica 
gel column chromatography (CC) using a CHCl3–EtOH gradient system (1:0 
to 1:1) to yield six fractions (TH1-4-1–TH1-4-6). Fraction TH1-4-3 (9.68 g) 
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was subjected to silica gel CC with a gradient system of n-hexane–EtOAc (1:0 
to 0:1) to give seven subfractions (TH1-10-1–TH1-10-7). Fraction TH1-10-4 
(4.7 g) was further isolated by silica gel CC with a gradient mixture of 
n-hexane–CHCl3–EtOH (1:0:0 to 0:1:1), resulting in sixteen subfractions 
(TH1-74-1–TH1-74-16). Fraction TH1-74-4 (1.4 g) was separated by 
Sephadex LH-20 CC eluted with CHCl3–EtOH (1:1) to yield eight 
subfractions (TH1-84-1–TH1-84-8). Fraction TH1-84-4 (552.0 mg) was 
separated using Sephadex LH-20 CC with CHCl3–EtOH (1:1), producing six 
subfractions (TH1-104-1–TH1-104-6). Fraction TH1-104-4 (191.7 mg) was 
purified by preparative HPLC (EtOH–H2O, 50–90% EtOH in H2O) to afford 
6,8-diprenylgenistein (7, 4.0 mg) (Sekine et al., 1999). TH1-74-12 (166.3 mg) 
was fractionated by RP C18 silica gel CC with a gradient system of EtOH–H2O 
(1:1 to 1:0) to give six subfractions (TH3-9-1 – TH3-9-6). Fraction TH3-9-1 
(71.0 mg) was then separated by silica gel CC with a gradient mixture of 
n-hexane–EtOAc (1:0 to 0:1), resulting in the preparation of five fractions 
(TH3-19-1 – TH3-19-5). Fraction TH3-19-3 (40.5 mg) and TH3-19-4 (12.3 
mg) were purified by preparative HPLC (EtOH–H2O, 60–81% EtOH in H2O), 
leading to the isolation of cudraisoflavones H (2, 4.2 mg )(Hiep et al., 2015b) 
and I (1, 5.8 mg) (Hiep et al., 2015b). Fraction TH1-10-5 (909.3 mg) was 
separated by Sephadex LH-20 CC eluted with CHCl3–EtOH (1:1) to yield 
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seven subfractions (TH3-51-1–TH3-51-7). Fraction TH3-51-5 (311.3 mg) was 
fractionated by silica gel CC using a gradient mixture of n-hexane–EtOAc (1:0 
to 0:1), producing eight fractions (TH3-69-1–TH3-69-8). Fraction TH3-69-3 
(95.3 mg) was subjected to silica gel CC with a gradient system of n-hexane–
EtOAc (1:0 to 0:1) to yield six subfractions (TH3-79-1–TH3-79-6). 
Furthermore, the first fraction (29.3 mg) was purified by preparative HPLC 
(EtOH–H2O, 60–95% EtOH in H2O), leading to isolation of 
alpinumisoflavone (5, 2.9 mg) (Hiep et al., 2015b) and gancaonin A (3, 2.8 
mg)(Hiep et al., 2015b). Fraction TH3-79-4 (51.2 mg) was further separated 
by preparative HPLC (EtOH–H2O, 60–95% EtOH in H2O) to afford 
isoerysenegalensein E (8, 40.3 mg) (Hiep et al., 2015b). The purification of 
fraction TH3-69-5 (64.6 mg) was carried out by preparative HPLC (EtOH–
H2O, 65–95% EtOH in H2O), leading to the isolation of erysenegalensein E 
(9, 38.6 mg)(Hiep et al., 2015b). Fraction TH1-10-6 (1672.0 mg) was 
fractionated by Sephadex LH-20 CC with CHCl3–EtOH (1:1), resulting in 
eleven subfractions (TH3-101-1–TH3-101-11). Fraction TH3-101-8 (243.8 
mg) was eluted on silica gel CC with n-hexane–EtOAc gradient system (1:0 
to 0:1), leading to preparation of five fractions (TH3-129-1–TH3-129-5). The 
purification of first fraction (16.7 mg) was carried out by semipreparative 
HPLC (EtOH–H2O, 60–85%, EtOH in H2O), to give 4′-O-
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methylalpinumisoflavone (6, 2.1 mg)(Olivares et al., 1982). Fraction TH1-4-4 
(2.30 g) was separated using Sephadex LH-20 CC with CHCl3–EtOH (1:1) to 
yield eight subfractions (TH4-21-1–TH1-21-8). Fraction TH4-21-7 (757.8 mg) 
was applied to silica gel CC eluted with gradient mixture of CHCl3–EtOH (1:0 
to 1:1), resulting in the preparation of 10 fractions (TH4-77-1–TH3-77-10). 
Fraction TH4-77-4 (76.4 mg) was purified by preparative HPLC (EtOH–H2O, 
50–95%, EtOH in H2O) to obtain 6,8-diprenylorobol (4, 26.9 mg) (Wang et 
al., 2013). 
 
2.4. SH-SY5Y cell culture 
The human neuroblastoma cell line SH-SY5Y (ATCC No. CRL-2266) was 
purchased from the American Type Culture Collection (Manassas, VA, USA) 
and cultured in DMEM supplemented with 10 % heat-inactivated FBS and 1 % 
penicillin/streptomycin at 37 ºC in a humidified atmosphere of 95% air 
and 5 % CO2. 
 




Briefly, SH-SY5Y cells were seeded at a density of 1×105 cells/200 μL/well 
in 96-well plates for 24 h, and then cells were treated with FME50 (0.08 - 2 
µg/mL), CFI, CFH and VAS2870 (0.016 - 4 µM), or vehicle and 
simultaneously OGD/R was performed as described previously (Hong et al., 
2017). Briefly, after treatment of samples, cells were incubated in a hypoxia 
chamber (Modular Incubator Chamber MIC-101, Billups-Rothenberg, Del 
Mar, CA) containing a mixture of 95% N2 and 5% CO2 at 37 °C for 16 h. After 
hypoxia, reoxygenation and glucose restoration were performed for an 
additional 24 h. In the normoxia control group, cells were cultured with 
DMEM containing glucose under normal conditions (5% CO2 at 37°C for 16 
h). 
 
2.6. Measurement of cell viability 
Cell viability was evaluated using MTT assay as previously described with a 
slight modification (Ghaffari et al., 2014a). Briefly, cell viability was 
determined by MTT dissolved in PBS (0.5 mg/mL) at 37 °C for 4 h. The 
formazan crystals were dissolved with dimethyl sulfoxide (DMSO). The 
number of viable cells was measured at 540 nm with a microplate reader 




2.7. Measurement of intracellular ROS 
SH-SY5Y cells were plated into 6-well plates at a density of 2×105 cells/2 
ml/well for 24 h and then cell treated with carnosine (0.08, 0.4 and 2 µM), or 
vehicle and then exposed to OGD/R condition. ROS were measured with 2',7'-
dichlorofluorescein diacetate (DCFH-DA), as previously described (Kim et al., 
2015). Briefly, cells were washed 3 times with PBS and incubated with 
DCFH-DA (4 µM) for 30 minutes at 37 ºC in the dark, then washed 3 times 
with PBS. Approximately 1x104 cells were used for each experiment and the 
fluorescence intensities were measured by flow cytometry (BD FACSCalibur 
TM). 
 
2.8. Measurement of Nox enzymatic activity in SH-SY5Y cells  
SH-SY5Y cells were plated into 6-well plates at a density of 2×105 cells/2 
ml/well for 24 h and then cells were treated with of FME50 (0.08, 0.4, and 2 
µg/mL) and CFI, CFH, or a NOX inhibitor VAS2870, and vehicle (0.016, 0.8, 
and 4µM) and simultaneously exposed to OGD/R condition. Nox activity was 
determined by lucigenin chemiluminescence assay, as described previously 
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(Lo et al., 2013). Briefly, SH-SY5Y cells were homogenized with a sonicator 
(Vibra cell-VCX130) in PRO-PREP® protein extraction solution (iNtRON 
Biotechnology, Korea). The reaction mixture (10 µM lucigenin, 150 mM 
EGTA, 50 mM sucrose, 100 µM NADPH) in 96-well white plate. The reaction 
performed in the dark for 5 minutes at room temperature. (Wissing and Smith, 
2000). The mean chemiluminescence observed by luminometer over 200 s in 
a scintillation counter (Centro LB 960, Berthold Technologies) at 5-s intervals 
and was calculated by subtracting the background values from those in the 
production of O2. The light emission was detected at 506nm (Lopez-
Sepulveda et al., 2011). 
 
2.9. Transfection of miRNA and RNA preparation 
SH-SY5Y cells were plated into 12-well culture plates at a density of 1.0×105 
cells/1 mL/well for 24 h and then cells were transfected with 200 nM of 
miRNA-25, miRNA-92a, miRNA-146a, and 200 nM of inhibitor miRNA-25, 
miRNA-92a, and miRNA-146a for 48 h in lipofectimine-2000 (Invitrogen, 
Carlsbad, CA). Moreover, samples and, a NOX inhibitor, VAS2970 (0.016 - 
4µM), or vehicle were treated and exposed to OGD/R condition. Total RNA 
was extracted from cells by Easy-Blue®. Briefly, RNA extraction were 
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centrifuged at 13,000×g for 15 minutes at 4°C and added DEPC-treated water 
to the RNA pellet. The purity and concentration of RNA were determined 
using NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, 
DE, USA). The pellet was used as the total RNA extract for qRT-PCR. 
 
2.10. Determination of Nox4 mRNA expression by quantitative RT-PCR 
(qRT-PCR) 
The total RNA (1 μg) was reverse transcribed to cDNA using cDNA synthesis 
Kit (with oligo(dt) 2X) (GeNet Bio, Cheonan, Korea). The cDNA amplify was 
performed using a Thermo Cycler PCR system 2720 (Applied Biosystems, 
Carlsbad, U.S.A.). The reaction were performed with a TOprealTM qPCR 2X 
PreMix (SYBR Green with high ROX) (Enzynomics, Hanam, Korea) using 
Thermo cycler Real-Time PCR systems 7300 (Applied Biosystems, Carlsbad, 
CA, USA). The PCR amplification was performed with following conditions: 
10 min at 95 ˚C, 45 cycles of 95˚C for 20s, 60˚C for 30s and 72 ˚C for 30s. The 
primers used were as follows:  
Nox4 forward: 5′-CTCAGCGGAATCAATCAGCTGTG-3′,  
Nox4 reverse: 5′-AGAGGAACACGACAATCAGCCTTAG-3′ (Pedruzzi et 
al., 2004),  
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β-actin forward: 5′-GACCCAGATCATGTTTGAGA-3′,  
β-actin reverse: 5′-GCTTGCTGATCCACATCTGC- 3′ (Hiney et al., 2010). 
Relative expression was calculated using a normalized ratio to the average Ct 
value of the β-actin (Farago et al., 2008) . 
 
2.11. Determination of miRNAs by quantitative RT-PCR (qRT-PCR) 
The miRNA reverse transcription reaction was performed with the 
Taqman®MicroRNA Reverse Transcription Kit (Applied Biosystems, CA, 
USA). Total RNA (350ng) from each treatment was reverse transcribed in the 
presence of 5×RT TaqMan® MicroRNA Assays kit (Applied Biosystems, CA, 
USA). Reaction mixture (8µl) contains 2.0 µl of dNTPs, 1.5µl of 
MultiScribeTM Reverse Transcriptase (50 U/µl), 0.8 µl of 10 X RT Buffer, 0.9 
of µl MgCl2, 0.1 µl of RNase inhibitor (20 U/µl), 1.5 µl of 5 X RT primer. 
The expression level of miRNAs was determined with 7300 Real-Time PCR 
systems (Applied Biosystems, Carlsbad, CA, USA). Reverse Transcription 
was carried out with the following cycling: 16°C for 2 min, 42°C for 1 min, 
50°C for 1 min, 50°C for 1 sec, 45 cycles, and then samples were hold at 85°C 




2.12. Protein Extraction  
SH-SY5Y cells were plated into 60π dishes at a density of 2.0×105 cells/4 
mL/well for 24 h with OGD/R condition. Protein was extracted with PRO-
PREP protein extraction solution (iNtRON Biotechnology, Korea) for 20 
minutes at -20 °C. Lysates were centrifuged at 13,000×g for 10 minutes at 4 °C 
and the supernatant was used for western blot analysis.  
 
2.13. Western blot assay 
Briefly, the protein was determine by Bradford assay (Jones et al., 1989), and 
equal amount of protein (15 μg) were electrophoresed by SDS-PAGE on a 10% 
gel, transferred to a PVDF membrane for 2 h, and then blocked with 5% skim 
milk in TBST for 2 h at room temperature. The membrane was incubated 
overnight at 4 °C with a primary antibody (Nox4, ASK1, p-ASK1, JNK, p-
JNK, p38, p-p38, cleaved caspase3, and caspase3 were diluted 1:2000, and β-
actin was diluted 1:5000) followed by incubation with a secondary antibody 
(anti-rabbit or anti-mouse HRP-conjugated IgG was diluted 1:5000) for 1 h at 
room temperature. The band intensity was detected using ImageQuantTM LAS 
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4000 (GE Healthcare Life Science, USA) image analyzer. The membrane was 
stripped and reprobed with anti-β-actin antibody as an internal control as 
previously described (Ham et al., 2013). 
 
2.14. Animals 
Male Sprague-Dawley rats were purchased from Samtako Bio Korea (Osan, 
Korea) and housed in groups (2~3 rats/cage) for experiment. The environment 
was maintained at 60% humidity with a 12/12-light-dark cycle and unlimited 
access to food and water. Male Sprague-Dawley rats 6-7 weeks after birth 
(200-210 g) were used. All animal experiments were approved by the 
Institutional Animal Care and Use committee of Seoul Nation University and 
performed in accordance with the requirements of European Directive 
2010/63/EU. All efforts were made to minimize the number of animals used 
and their pain. After each experiment, animals were euthanized by an overdose 
of anesthetics. 
 
2.15. Application of FME50 for Animals 
The FME50 and carnosine, a control compound, were dissolved in saline, and 
administered orally for once a day at a dose 25, 50 and 100 mg/kg of FME50 
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and 75, 150 and 300 mg/kg of carnosine for 7 days. The animals were divided 
into 4 groups of 6 rats including a sham surgery control, a vehicle-treated 
MCAO/R, a FME50-treated MCAO/R, and a carnosine-treated MCAO/R 
groups. 
 
2.16. Middle cerebral artery occlusion/reperfusion (MCAO/R) 
Rats were anesthetized with 2-3% isoflurane (Aerrane®) purchased from 
Baxter (Deerfield, Illinois, USA) in a mixture of 30% O2 and 70% N2O 
through a face mask during surgery. Body temperature was maintained at 37 
± 0.5°C with a heating pad. Focal cerebral ischemia was induced by 
intraluminal MCAO as previously described (Truong et al., 2012). In brief, 
the right external carotid artery (ECA), the common carotid artery (CCA), and 
the internal carotid artery (ICA) branches were separated from surrounding 
nerves and fascia. Then, the middle cerebral artery (MCA) was occluded with 
a 3-0 poly-L-lysine-coated nylon suture through the extracranial ICA for 2 h. 
Reperfusion was performed by removing the suture. The sham-operated 
control group received all surgical procedures except suture occlusion process. 
After the MCAO/R surgery, animals were provided unlimited access to food 




2.17. Determination of infarct volume 
To evaluate the infarct volume, the brains were carefully removed within 3 
minutes of euthanasia. They were cut into five coronal sections of 2-mm 
thickness by rat brain matrix purchased from Harvard Bioscience (Holliston, 
MA, U.S.A.). The slices were placed in 24-well plates and stained with 2% 2, 
3, 5-triphenyltetrazolium chloride (TTC) at 37 °C for 30 minutes, then fixed 
with 4% paraformaldehyde solution. The unstained white area of the brain 
slice was defined as the infarction, and the infarct volume ratio was measured 
and calculated using a computerized image analyzer using Image J Software 
(NIH, Maryland, USA) as previously described (Cho et al., 2010). Briefly, the 
percentage infarct volume was calculated as: [(VC – VL)/VC] ×100, where VC 
is the volume of control hemisphere and VL is the volume of non-infarcted 
tissue in the lesioned hemisphere. 
 
2.18. RNA preparation from rat brain 
For RNA preparation, extraction of total RNA was the purification of RNA 
from homogenized cortex by Easy-Blue®. RNA extraction were centrifuged at 
13,000×g for 15 minutes at 4 °C and added DEPC treated water to the RNA 
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pellet. The purity and concentration of RNA were determined using NanoDrop 
1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). The 
total RNA extract was used as for qRT-PCR procedures. 
 
2.19. Protein Extraction from rat brain 
The homogenized cortex was lysed in PRO-PREP protein extraction solution 
(iNtRON Biotechnology, Korea) for 20 minutes at -20 °C. Lysates were 
centrifuged at 13,000×g for 10 minutes at 4 °C and the supernatant was used 
as the total brain protein extract for immunoblotting procedures. 
 
2.20. Statistical analysis 
All experimental data are expressed as the mean value ± standard deviation 
from three different experiments. Statistical significance between multiple 
groups was determined by one-way ANOVA (PRISM Graph Pad, San Diego, 
CA, USA). When ANOVA had a significant difference, post hoc Bonferroni’s 
multiple comparison tests was conducted. P value less than 0.05 was regarded 
to be statistically significant.  
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3. Results  
 
3.1. Neuroprotective effects of M. tricuspidata in SH-SY5Y cells 
Ethanol is commonly used to extract bioactive compounds from plant 
materials. The ratio of water to ethanol can influence on the bioactivity of 
plant extracts (Ganora, 2009). We evaluated the neuroprotective effects of M. 
tricuspidata fruits and leaves extract (0, 30, 50, 70, and 100% ethanol) within 
nontoxic concentration ranges. As shown in Fig 1 and Table. 1, the extract of 







Table. 1. Neuroprotection of the percent of EtOH extracts from the fruits and 






Fig. 1. The graph of neuroprotection of the percent of EtOH extracts from the 
fruits and leaves of M. tricuspidata against in ODG/R-induced SH-SY5Y cells 
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3.2. Protective effects against OGD/R-induced neuronal cell death in SH-
SY5Y cells 
The constituents of FME50 were identified using UPLC, and nine compounds 
were isolated (Fig. 3). As shown in Fig 2A and Table. 2, FME50 showed potent 
protective effect with an EC50 value of 1.9 μg/mL. Among nine isolated 
compounds from FME50, two isoflavone compounds (CFI and CFH) 
significantly attenuated OGD/R-induced neurotoxicity with EC50 values of 3.3 
μM, and 11.4 μM, respectively (Fig. 2A and Table. 2), whereas the other 
compounds revealed no significant effects (Table. 2). The Nox inhibitor of 
VAS2870, a control compound, also protected neuronal cells with an EC50 of 






Table. 2. Neuroprotection of isolated compounds of M. tricuspidata against 
in ODG/R-induced SH-SY5Y cells. The values were determined in a 
semilogarithmic graph with 4 different concentrations of test materials. At 
least 3 independent experiments were performed. VAS2870, a Nox inhibitor, 





 Fig. 2. The effect of FME50, CFI, CFH or VAS2870 on OGD/R-induced cell 
death in SH-SY5Y cells was measured by an MTT reduction assay. The cells 
were treated with different concentrations of FME50 (0.08 – 2 μg/ml) or 
VAS2870 (0.016 – 4 μM) and exposed to OGD/R conditions (A). Data 
represent the mean ± SD of three independent experiments. (***p<0.001 
compared to the control group, #p<0.05, ##p<0.01 and ###p<0.001 compared to 




Fig. 3. Structures of the principal compounds and UHPLC chromatogram of 






Fig. 4. (B) UHPLC chromatogram of FME50. The principal compounds are 
cudraisoflavone I (1), cudraisoflavone H (2), 5,7-dihydroxy-6-(2”-hydroxy-
3”-methylbut-3”-enyl)-4'-methoxylisoflavone (3), gancaonin B (4), gancaonin 




3.3. Inhibitory effects against OGD/R-induced intracellular ROS 
generation in SH-SY5Y cells 
It has been reported that ROS generated by Nox enzyme induces neuronal cell 
death and is closely linked to cerebral ischemia (Nomura et al., 2004; 
Matsuzawa et al., 2002). As shown in Fig. 4B and Table. 3, FME50 showed 
the potent inhibition of OGD/R-induced ROS generation with an IC50 value 
of 3.5 μg/mL. Among the nine compounds derived from FME50, CFI and 
CFH showed a significant inhibitory effect against OGD/R-induced ROS 
generation with IC50 values of 5.8 μM, 13.3 μM, respectively (Fig. 4A and 
Table. 1). VAS2870 also inhibited ROS generation in OGD/R-induced SH-





Table. 3. Neuroprotection of isolated compounds of M. tricuspidata against 
inhibition of ROS generation in ODG/R-induced SH-SY5Y cells. The values 
were determined in a semilogarithmic graph with 4 different concentrations of 
test materials. At least 3 independent experiments were performed. VAS2870, 





Fig. 5. The effects of FME50 on OGD/R-induced intracellular ROS generation 
in SH-SY5Y cells are illustrated by DCFH-DA staining. The cells were treated 
with different concentrations of FME50 (0.08 – 2 μg/ml) or VAS2870 (0.016 
– 4 μM) (A) and exposed to OGD/R conditions. Data represent the mean ± SD 
of three independent experiments. (***p<0.001 compared to the control group, 
#p<0.05, ##p<0.01 and ###p<0.001 compared to the OGD/R-induced group). 
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3.4. Inhibitory effects against OGD/R-induced Nox4 mRNA expression in 
SH-SY5Y cells 
Nox4 is stimulated by external stress or brain injury generates ROS, 
suggesting that ROS generation by the Nox4 activation plays a key role in 
cerebral ischemia (Bedard and Krause, 2007). As shown in Fig. 6, OGD/R-
induced cells exhibited the increase of Nox4 mRNA expression. When cells 
were treated with different concentrations of FME50 (0.08 – 2 μg/mL), CFI, 
and CFH (0.016 – 4 μM), the expression of Nox4 mRNA were decreased to 
normal in a concentration-dependent manner (Fig.6). FME50 (2 μg/mL), CFI, 
and CFH (4 μM) almost restored to normal state of Nox4 mRNA expression. 
Similarly, a Nox inhibitor VAS2870 decreased the Nox4 mRNA expression in 





Fig. 6. The inhibitory effects of FME50, CFI, CFH or VAS2870 on the 
expression of Nox4 mRNA (A). Nox4 mRNA expression was evaluated by 
RT-PCR assay, and Nox enzyme activity in SH-SY5Y cell was evaluated 
using lucigenin after treatment with different concentrations of FME (0.8 – 2 






3.5. Inhibitory effect against OGD/R-induced down-regulation of 
miRNA-25, miRNA-92a, and miRNA-146a in SH-SY5Y cells 
To evaluate the effect of FME50, CFI, and CFH on Nox4-targeting three 
miRNAs expression, we performed the qRT-PCR assay. The expression of 
miRNA-25, miRNA-92a, and miRNA-146a was decreased by OGD/R 
condition (Fig. 7). FME50, CFI, and CFH attenuated OGD/R-induced 
decrease of Nox4-targeting three miRNAs expression in SH-SY5Y cells. 
FME50 (2 μg/mL), CFI, and CFH (4 μM) almost restored to a normal level of 
Nox4-targeting three miRNAs expression (Fig. 7A – C). VAS2870 also 
restored OGD/R-induced three miRNAs expression in a concentration-






Fig. 7. Quantitative comparison of the miRNA-25, miRNA-92a, and miRNA-
146a level in the OGD/R-induced condition in SH-SY5Y cells. The cells were 
treated with different concentrations of FME50 (0.08 – 2 μg/ml), CFI, CFH, 
or VAS2870 (0.16 – 4 μM) (A-C). The results were expressed as fold change 
compared with the OGD/R condition. Data represent the mean ± SD of three 





3.6. Inhibitory effect against OGD/R-induced Nox enzyme activity in SH-
SY5Y cell 
Based on the results of Nox4 mRNA expression, we examined the inhibitory 
effect of FME50, CFI, and CFH on Nox enzyme activity. The Nox enzyme 
activity was significantly increased in OGD/R-induced SH-SY5Y cells. 
However, FME50, CFI, and CFH inhibited OGD/R-induced Nox enzyme 
activity in a concentration-dependent manner with an IC50 values of 1.1 µg/mL, 
2.7 µM, and 1.9µM, respectively (Fig. 8). Also, VAS2870 inhibited Nox 






Fig. 8. The inhibitory effects of FME50, CFI, CFH or VAS2870 on the 
expression of Nox enzyme activity (A). Nox4 mRNA expression was 
evaluated by RT-PCR assay, and Nox enzyme activity in SH-SY5Y cell was 
evaluated using lucigenin after treatment with different concentrations of 
FME50 (0.08 – 2 μg/ml), CFI, CFH or VAS2870 (0.016 – 4 μM) and exposure 
to OGD/R condition. 
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3.7. Inhibitory effect of FME50 on NADPH oxidase (NOX) enzyme 
activity in whole cell lysates 
The inhibitory effect of FME50 and VAS2870 on NOX enzyme activity was 
measured using SH-SY5Y whole cell lysates. As shown in Fig. 9, NOX 
enzyme activity was inhibited FME50 or VAS2870 with an IC50 values of 5.6 
µg/mL and 14.7 µM, respectively. The inhibitory potency of NOX enzyme by 






Fig. 9. The inhibitory effects of FME50 or VAS2870 on Nox enzyme activity 
(A). Nox enzyme activity in SH-SY5Y cell was evaluated using lucigenin after 
treatment with different concentrations of FME50 (0.08 – 50 μg/ml), or 
VAS2870 (0.08 – 20 μM). Data represent the mean ± SD of three independent 




3.8. Inhibitory effects against OGD/R-induced Nox4 mRNA expression  
It was reported that miRNA-25, miRNA-92a, and miRNA-146a down-
regulated Nox4 mRNA expression (Fu et al., 2010; Wang et al., 2014; Tsao et 
al., 2015). In correlated with previous study, Nox4-related three miRNAs 
mimic inhibited OGD/R-induced Nox4 mRNA expression (Fig. 10). However, 
three miRNAs inhibitor exacerbate OGD/R-induced increase of Nox4 mRNA 






Fig. 10. Quantitative comparison of Nox4 mRNA level in OGD/R-induced in 
SH-SY5Y cell. The cells were transfected with 200nM of three different 
miRNAs scrambled, mimics and inhibitor (A) and exposed to OGD/R 
conditions Data represent the mean ± SD of three independent experiments. 





3.9. Inhibitory effect against OGD/R-induced ASK1-JNK/p38 MAPK 
apoptotic signaling pathway 
 It has been reported that OGD/R condition induces excessive ROS 
accumulation by Nox4 activation. The excessive ROS generation induces 
apoptosis through phosphorylating ASK1-JNK/p38 MAPK factors which are 
the evidence of MAPK signal activation (Lai et al., 2007). In our results, 
OGD/R condition increased the Nox4 protein expression. Also, OGD/R 
increased phosphorylation of ASK-1, JNK1, and p38 protein and cleavage of 
caspase3 (Fig. 11). FME50, CFI, and CFH attenuated OGD/R-induced 
increase of Nox4 protein and increase of phosphorylated ASK-1, JNK1, and 
p38 protein in a concentration-dependent manner (Fig. 11A - C). In addition, 
FME50, CFI and CFH inhibited the cleavage of caspase-3 (Fig. 11A - C). As 
shown in Fig. 10D, VAS2870 restored OGD/R-induced changed protein 
expression of Nox4, p-ASK1, p-JNK1, p-p38, and cleaved caspase3 to normal 




Fig. 11. Inhibitory effects of FME50, CFI, CFH or VAS2870 on the expression 
levels of Nox4, p-ASK1, ASK1, p-JNK1, JNK1, p-p38, p38 and β-actin were 
evaluated by western blot analysis. The cells were treated with different 
concentrations of FME50 (0.08 – 2 μg/ml) (A), CFI, CFH, or VAS2870 (0.016 
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– 4 μM) (B-D) and exposed to OGD/R conditions. Data represent the mean ± 
SD of three independent experiments. (***p<0.001 compared to the control 





3.10. Protective effect of carnosine against OGD/R-induced cytotoxicity 
in SH-SY5Y cells 
The protective effect of carnosine against OGD/R-induced neuronal cell 
death was evaluated by MTT assay within nontoxic concentration ranges. As 
shown in Fig. 11A, the cell viability of OGD/R-induced group was decreased 
compared to the normal control group. In contrast, carnosine (0.08, 0.4, and 2 
µM) protected against OGD/R-induced cell death in a concentration-




3.11. Inhibitory effect of carnosine against OGD/R-induced intracellular 
ROS generation in SH-SY5Y cells 
Intracellular ROS was measured by DCFH-DA. DCFH-DA is diffuses 
through the cell membrane and is deacetylated by cellular esterase. Through 
this process, DCFH-DA makes its non-fluorescent form, 
dichlorodihydrofluorescein (DCFH). DCFH can be rapidly oxidized by 
intracellular ROS and converts to the highly fluorescent form, 
dichlorofluorescein (DCF) (Ratner et al., 1987). As shown in Fig. 11B, the 
OGD/R-induced cells exhibited strong DCF fluorescence intensity compared 
to normal control group. The extent of OGD/R-induced ROS production was 






Fig. 12. The effect of carnosine on OGD/R-induced cell death in SH-SY5Y 
cells was measured by an MTT reduction assay. The cells were treated with 
different concentrations of carnosine (0.08 – 2 μg/ml) exposed to OGD/R 






Fig. 13. The effects of carnosine on OGD/R-induced intracellular ROS 
generation in SH-SY5Y cells are illustrated by DCFH-DA staining. The cells 
were treated with different concentrations of carnosine (0.08 – 2 μM) (B) and 
exposed to OGD/R conditions. Data represent the mean ± SD of three 
independent experiments. (***p<0.001 compared to the control group, #p<0.05, 
##p<0.01 and ###p<0.001 compared to the OGD/R-induced group). 
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3.12. Protective effect against MCAO/R-induced brain infarct  
 The neuroprotective effect of FME50 was evaluated in MCAO/R-induced 
ischemic rats by measuring the reduction ratio of infarct volume (Fig. 12). As 
shown in Fig. 12, the dose of administration was used within non-toxic ranges 
and the infarct volume was estimated. The infarct volume of FME50-treated 
groups (25, 50, and 100 mg/kg) were decreased to 33.0 ± 1.3%, 24.0 ± 4.2%, 
and 18.0 ± 3.6%, respectively, whereas vehicle-treated group was 47.9 ± 1.5% 
(Fig. 12). In subsequent experiments, carnosine, reported that it has 
neuroprotective effect on the early stage of focal ischemia, was used as a 
control compound. The infarct volume of carnosine-treated groups (25, 50, 
and 75 mg/kg) was reduced to 35.6 ± 4.2%, 22.0 ± 3.5%, and 13.6 ± 5.2%, 
respectively (Fig. 12). In our results showed that FME50 provided a potent 







Fig. 14. The effects of FME50 on the MCAO/R-induced cerebral infarct 
volume in the rat brain. 
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Five consecutive, 2-mm-thick slices were stained with TTC to visualize the 
MCAO/R-induced infarct volume in the rat brain. Representative images of 
rat brain slices are shown from each group treated with FME50 (25 - 100 
mg/kg) or carnosine (75 – 300 mg/kg). Data represent the mean ± SD of six 
independent experiments (A). The infarct volume ratio in each group was 
quantified using ImageJ software, and the quantitative value was shown as a 




3.13. Inhibitory effect against MCAO/R-induced reciprocal down-
regulation of miRNA-25, miRNA-92a, and miRNA-146a 
Nox4 plays a major role in the pathological signaling pathway of cerebral 
ischemia. MiRNA-25, miRNA-92a, and miRNA-146a is one of regulators to 
protect neuronal cell death by inhibiting Nox4 mRNA expression (Fu et al., 
2010; Wang et al., 2014; Tsao et al., 2015). The Nox4-targeting three miRNAs 
were significantly decreased in MCAO/R-induced group (Fig. 13). 
Additionally, carnosine-treated group (75-300 mg/kg) attenuated the increase 
of Nox4 protein and decreased of three miRNAs expression in MCAO/R-







Fig. 15. Quantitative comparison of miRNA-25, miRNA-92a, and miRNA-
146a levels in MCAO/R-induced rats. The rats were treated with different 
concentrations of FME50 (25 - 100 mg/kg) or carnosine (75 – 300 mg/kg) (A-
C) and exposed to MCAO/R conditions. Data represent the mean ± SD of 
three independent experiments. (#p<0.05, ##p<0.01 and ###p<0.001 compared 
to the control group)  
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3.14. Inhibitory effect against MCAO/R-induced reciprocal up-regulation 
of Nox4 mRNA  
The inhibitory effect of FME50 against MCAO/R–induced Nox4 mRNA 
expression was measured by RT-PCR analysis. It has been reported that the 
Nox family plays a crucial role in the pathological signaling pathway induced 
by cerebral ischemia. In particular, Nox4 is expressed in neuronal tissues and 
plays a critical role in the production of ROS in brain tissue (Bedard and 
Krause, 2007). The Nox4 mRNAs were significantly decreased in MCAO/R-
induced group compared to the sham control group (Fig. 14). Additionally, 
carnosine-treated group (75-300 mg/kg) attenuated the decrease of Nox4 






Fig. 16. The inhibitory effects of FME50 or carnosine on the expression of 
Nox4 mRNA. Nox4 mRNA expression of rats treated with FME50 (25 - 100 
mg/kg) or carnosine (75 – 300 mg/kg) and exposed to MCAO/R conditions 
(A). Data represent the mean ± SD of three independent experiments. (#p<0.05, 




3.15. Inhibitory effect against MCAO/R-induced ASK1-JNK/p38 MAPK 
apoptotic signaling pathway 
The activation of MAPK pathway by excessive ROS induces apoptosis (Choi 
et al., 2009). As shown in Fig. 15, Nox4 protein expression was significantly 
increased in MCAO/R-induced group compared to the sham control group. 
However, FME50-treated groups (25, 50 and 100 mg/kg) and carnosine-
treated groups (75, 100, and 300 mg/kg) decreased Nox4 protein expression. 
The MCAO/R-induced brain injury caused the activation of ASK1-JNK/p38 
MAPK apoptotic signaling pathway by phosphorylating ASK1, JNK1, and p-
p38. Also, the cleavage of caspase-3 was increased after MCAO/R-induced 
brain injury. However, FME50-treated groups (25, 50 and 100 mg/kg) 
inhibited the phosphorylation of ASK1, JNK1, and p38 and cleavage of 
caspase-3 (Fig. 15A). Carnosine-treated groups (75, 100, and 300 mg/kg) also 
inhibited activation of MAPK signal cascades (Fig. 15B). Hence, FME50 and 
carnosine protected MCAO/R-induced apoptosis via the inhibition of MAPK 




Fig. 17. The effect of FME50 on protein expression in MCAO/R-induced rat 
brain injury. The protein expression levels of Nox4, p-ASK1, ASK1, p-JNK1, 
JNK1, p-p38, p38 and β-actin in ischemic cerebrum of rats treated with 
FME50 (25 - 100 mg/kg) (A) or carnosine FME50 (75 - 300 mg/kg) were 
evaluated by western blots. Representative images from six independent 
experiments are shown. 
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3.16. Inhibitory effect against OGD/R-induced reciprocal up-regulation 
of Ago1 and Ago2 mRNA  
MicroRNAs associate with protein of the Ago family gorming 
ribonucleoprotien complexes (RISCs) that regulate gene expression at 
transcriptional or post-transcriptional level. miRNAs are derived from 
endogenously encoded genes, some of which are found in cluster, in inter or 
intragenic regions of protein coding genes. FME50-treated group (0.08 – 2 
µg/mL) markedly inhibited OGD/R-induced decrease of Ago1 and Ago2 
mRNA expression (Fig. 16 and Fig. 17). The results were correlated with the 
results of in vitro model. Additionally, CFI and CFH-treated group (0.016 – 4 
µM) attenuated the decrease of Ago1 and Ago2 mRNA expression in OGD/R-





Fig. 18. Quantitative comparison of Ago1 mRNA level in OGD/R-induced in 
SH-SY5Y cell. Ago1 mRNA expression was evaluated by RT-PCR assay. The 
cells were treated with different concentrations of FME50 (0.08 – 2 μM) or 
CFI, CFH, VAS2870 (0.016 – 4 μM) and exposed to OGD/R conditions Data 
represent the mean ± SD of three independent experiments. (#p<0.05, ##p<0.01 





Fig. 19. Quantitative comparison of Ago2 mRNA level in OGD/R-induced in 
SH-SY5Y cell. Ago2 mRNA expression was evaluated by RT-PCR assay. The 
cells were treated with different concentrations of FME50 (0.08 – 2 μM) or 
CFI, CFH, VAS2870 (0.016 – 4 μM) and exposed to OGD/R conditions Data 
represent the mean ± SD of three independent experiments. (#p<0.05, ##p<0.01 






Ischemic stroke is a leading cause of death and long-lasting disability, but 
therapeutic options remain limited and not clearly verified. Recent research 
suggested that miRNAs play crucial role in pathogenesis of cerebral ischemia 
brain injury (Junn and Mouradian, 2012). MicroRNAs are targeting a single 
gene by transcriptional control and cellular redox regulation(Ouyang et al., 
2015). After maturation, microRNAs are single stranded RNA molecules to 
derived long hairpin-precursor known as pre-miRNA. The pre-miRNA is 
transported to cytoplasm and microRNAs loaded onto the RISC complex can 
bind a direct target of mRNA 3’-untranslated region (3’-UTR). The binding of 
miRNAs leads to regulate the mRNA expression of target proteins (Lancon et 
al., 2013). A recent study reported that miRNA-25, miRNA-92a, and miRNA-
146a acted as a critical regulator of Nox4 in neuronal cell (Jeyaseelan et al., 
2008). In correlated with previous research results, Nox4-related three 
miRNAs contributed to the regulation of Nox4 expression in SH-SY5Y cells. 
Nox4 is a member of the NADPH oxidase family and activation of Nox4 
increases intracellular ROS (Siuda et al., 2012). The excessive ROS 
generation induces cellular stress and damages organelles. Also, it induces 
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apoptosis via activation of ASK1-JNK/p38 MAPK signaling pathway 
(Mochizuki et al., 2006). The redox sensor proteins thioredoxin (Trx) inhibit 
the kinase activity of ASK1 through binding to ASK1. Once eexcessive ROS 
was generated, Trx is unable to associate with ASK1. Hence, the activated 
ASK-1 induces the phosphorylation of JNK1 and p38 (Mantzaris et al., 2016). 
Finally, p-p38 induces activation of caspase-3 by making cleaved form of 
caspase-3, which is the key factor involved in the apoptotic process in 
neuronal cell (Ghosh et al., 2011). Thus, the inhibition of Nox4 expression 
and Nox enzyme activity through the up-regulation of Nox4-related three 
miRNAs is one of primary mechanisms regulating excessive ROS generation, 
and ASK1-JNK/p38 MAPK signal mediated apoptosis. 
In the present study, OGD/R-induced ROS generation and neuronal cell 
death was attenuated in a concentration-dependent manner when cells were 
treated with different concentrations of FME50, CFI, and CFH. To investigate 
how FME50, CFI, and CFH inhibited OGD/R-induced ROS generation, we 
evaluated the effects of them on the Nox4 protein expression and Nox enzyme 
activity. Recent study demonstrated that Nox in neurons produced intracellular 
ROS under ischemic conditions (Vallet et al., 2005). In our results, Nox4 
protein and enzyme activity were increased in OGD/R model, whereas Nox4 
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protein and enzyme activity were markedly reduced by FME50, CFI, and CFH 
treatment. Also, VAS2870, known as Nox inhibitor, attenuated OGD/R-
induced Nox4 protein and enzyme activity and OGD/R-induced ROS 
generation. The results demonstrated that Nox4 inhibition reduced OGD/R-
induced excessive ROS generation in SH-SY5Y cells. Additionally, FME50, 
CFI, and CFH protected OGD/R-induced intracellular ROS generation and 
cell death via inhibition of Nox4 protein and enzyme. To elucidate the 
underlying mechanism of Nox4 inhibitory effect, we examined the miRNAs 
which are known as a regulator of Nox4. It was previously demonstrated that 
miRNA-25, miRNA-92a, and miRNA-146a inhibited Nox4 mRNA 
expression (Fu et al., 2010; Wang et al., 2014; Tsao et al., 2015). To confirm 
the effect of Nox4-targeting miRNAs on Nox4 expression, we examined the 
effects of mimics and inhibitors of Nox4-targeting three miRNAs on OGD/R-
induced Nox4 mRNA expression. In correlated with the results of previous 
studies, miRNA mimic transfection significantly inhibited OGD/R-induced 
Nox4 mRNA expression. However, miRNA inhibitors slightly increased 
OGD/R-induced Nox4 mRNA expression. We evaluated the effects of FME50, 
CFI, and CFH on miRNA-25, miRNA-92a, and miRNA-146a expression. 
FME50, CFI, and CFH significantly increased the all of Nox4-targeting three 
miRNAs expression in a concentration-dependent manner. FME50, CFI, and 
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CFH showed no selectivity on three miRNAs. The results can be interpreted 
that argonaute, up-stream factor of miRNAs, will be regulated by FME50, CFI, 
and CFH and argonaute regulated all of three miRNAs. To reveal this 
hypothesis, further study should be conducted in the near future. The results 
suggested that FME50, CFI, and CFH inhibited OGD/R-induced Nox4 
activation by up-regulation of Nox4-targeting three miRNAs and ultimately 
protected OGD/R-induced excessive ROS generation and neuronal cell death 
in SH-SY5Y cell. A growing body of evidence suggested that ROS-mediated 
ASK1 activation plays an important role in OGD/R-induced apoptosis in 
neurodegenerative diseases and several studies suggested that ASK1-targeted 
drugs expected to mitigate neurodegenerative diseases (Ichijot et al., 2009). 
The OGD/R-induced cell exhibited the significant increase of p-ASK1, p-
JNK1, p-p38, and cleaved caspase3 protein expression. This results show that 
OGD/R-induced ROS activates ASK1-JNK3/p38 MAPK apoptotic signal and 
induces neuronal cell death (Mantzaris et al., 2016; Ghosh et al., 2011). In our 
results, FME50, CFI, and CFH suppressed OGD/R-induced activation of 
MAPK apoptotic signal. Also, VAS2870 inhibited MAPK apoptotic signal 
activation. This result suggested that the protective effect of FME50, CFI, and 
CFH on OGD/R-induced ROS suppressed the activation of MAPK apoptotic 
signal and protected neuronal cell death.  
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Based on the results of in vitro model, we conducted the experiment about 
FME50 using MCAO/R in vivo model of cerebral ischemia. In correlated with 
the result of in vitro model, FME50 elicited its neuroprotective effects against 
MCAO/R-induced brain infarct. Also, carnosine which was reported that it 
has neuroprotective effects in the early stage of focal ischemia and protects 
brain tissues and mitochondrial dysfunction from oxidative brain damage 
(Baek et al., 2014; Park et al., 2014) was used as a positive control compound 
and it exhibited protective effect with a dose dependent manner. The results 
showed that FME50 provided more potent neuroprotective effect against 
MCAO/R-induced brain infarct than carnosine. The previous study 
demonstrated that excessive ROS is generated by Nox4 after MCAO/R-
induced stroke models in mice (Nishimura et al., 2016). On the basis of the 
results about Nox4 protein expression and Nox4-targeting miRNA-25, 
miRNA-92a, and miRNA-146a expression in in vitro model, we evaluated the 
effects of FME50 and carnosine on Nox4 mRNA, protein expression and 
Nox4-targeting three miRNAs expression in in vivo model. The Nox4 mRNA, 
protein expression was increased in the MCAO/R-induced brain, whereas 
FME50-treated group and carnosine-treated group attenuated the increase of 
MCAO/R-induced Nox4 mRNA, protein expression. Also, Nox4-targeting 
three miRNAs was decreased in the MCAO/R-induced brain. However, 
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FME50-treated group and carnosine-treated group restored the MCAO/R-
induced miRNAs expression to normal state. This result was correlated with 
that of in vitro model. Additionally, we investigated the ASK1-JNK1/p38 
MAPK signal cascade. It was reported that MCAO/R condition exacerbates 
ROS generation in neuron (Chouchani et al., 2014). Because of excessive ROS, 
MAPK apoptotic signal is activated in MCAO/R-induced brain. In our results, 
phosphorylation of AKS1, JNK1, and p38 and cleavage of caspase3 were 
increased in MCAO/R-induced brain. FME50-treated group and carnosine-
treated group inhibited MCAO/R-induced activation of MAPK signal cascade 
and protected brain infarct. Consistent with the result of in vitro model, 






This study demonstrated the neuroprotective effects of FME50, CFI, and 
CFH on in vitro and in vivo models of cerebral ischemia. FME50 protected 
OGD/R-induced neuronal cell death and excessive ROS generation in in vitro 
model. Also, FME50 protected MCAO/R-induced brain infarct in in vivo 
model. FME50 significantly suppressed Nox4 mRNA, protein expression by 
regulating Nox4-targetomg miRNA-25, miRNA-92a, and miRNA-146a and it 
attenuated the ASK1-JNK/p38 MAPK apoptotic signal pathway. Additionally, 
CFI and CFH, one of compounds from FME50, showed protective effect 
against OGD/R-induced ROS generation and cell death. CFI and CFH also 
exhibited the regulatory effects on Nox4, Nox4-targeting miRNAs, and 
MAPK apoptotic signal pathway. Taken together, we suggest that FME50, CFI, 







Fig. 20. A scheme of the inhibitory effects of FME50, CFI, and CFH on Nox4 
mRNA targeting miRNAs signaling in SH-SY5Y cells. FME50, CFI, and CFH 
inhibited ASK1-JNK/p38 MAPK apoptotic signal pathway. The Nox4-
targetomg miRNA-25, miRNA-92a, and miRNA-146a significantly 
upregulated by FME50, CFI, and CFH. In addition, FME50, CFI, and CFH 
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Nox4 mRNA를 표적으로하는 miRNA의 유도를 통한 꾸지뽕나무 열
매 추출물과 분리된 컴파운드의 허혈성 손상 세포 및 동물에서의 모
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 퇴행성 뇌질환은 많은 복합적 원인에 의해 발병하는 질환이
며 고령화 사회로 인하여 질병의 추이가 계속 높아지고 있다. 뇌졸
증으로 인해 발생하는 합병증으로는 편측마비, 안면마비, 구음장애 
등이 있으며 치료로 회복하기도 한다. 이에 뇌졸증을 일으키는 원
인의 예방도 중요하지만 치료제의 투여로 합병증 및 뇌졸증 치료
가 필요한 실정이다. 다음의 연구에서는 천연물질인 꾸지뽕을 이용
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하여 뇌졸증 치료제로서의 효과를 입증하고자 하였다. 
본 연구에서는 뇌허혈모델인 산소-포도당 결핍(oxygen-
glucose deprivation) 과 중뇌동맥협착(middle cerebral artery occlusion) 
을 통해서 활성산소종(ROS)를 과 발현시키는 Nox4의 억제와 Nox4
의 표적 miRNA를 통해 뽕나무 열매의 추출물 FME50과 열매에서 
분리된 단일물질인 cudraisoflavone I 와 cudraisoflavone H가 활성산소
종을 억제하고 miRNA를 통해 Nox4를 억제 효능을 확인할 수 있는 
실험을 진행하였다.  하여 산소-포도당 결핍이 유도된 SH-SY5Y cell
과 흰쥐의 뇌 에서 세포실험과 동물실험을 통해서 꾸지뽕 열매의 
추출물 FME50 과 분리된 물질 cudraisoflavone I 와 cudraisoflavone H
을 처리한 군의 손상이 농도 구배적으로 회복되어 뇌 신경세포의 
보호 효과가 있다는 것을 확인하였다. 또한 소포체 스트레스를 일
으키는 외부 원인 중 하나인 활성 산소종(reactive oxygen specis, ROS)
의 생성으로 소포체 스트레스에 영향을 주어 세포 사멸의 매게 인
자들인 Nox4와 MAPkinas를 활성화 시키며 그에 따른 기전에 대한 
규명을 하고자 하였다. 
본 연구를 통해 퇴행성 뇌질환의 하나인 허혈성 뇌질환의 
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치료제의 개발에서 microRNA와 과도한 활성산소종으로 인해 세포 
고사를 야기시키며, 세포사멸사를 일으키는 주요한 단백질인 Nox4, 
ASK1, JNK, p38을 억제하고 허혈/재관류에 의해 유도된 뇌에서의 





주요어: 산소 및 포도당 결핍, 허혈/재관류 수술, 허혈성 뇌졸증, 
활성 산소종 (ROS), 꾸지뽕, MAPkinase 
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